HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Progressive and concordant expression of PKC-eta and iNOS phenotypes in monocytes from patients with rheumatoid arthritis: association with disease severity.

Abstract
Rheumatoid arthritis (RA) is a relatively common autoimmune disease with strong genetic and environmental determinants. The disease manifests itself as inflammation of the synovia and usually progresses to joint erosion and destruction. The disease can also be considered as a systemic disease because extra-articular manifestations are often observed throughout many organs and tissues of the body. Patients with severe RA have altered peripheral blood monocytes (PBM) that express activation markers. Two such markers, PKC-eta and iNOS, were studied using confocal laser scanning microscopy to determine how these markers are expressed during disease progression. Healthy individuals expressed neither of the two markers, but there was an elevated level of PKC-eta observed as the disease progressed (40% in mild RA and 100% in severe RA patients). Concordant expression of the two markers was observed in only 3% of PBM from mild RA patients, reaching 38% in severe RA patients. No cells expressing iNOS alone were observed in any of the patients studied. These data support the hypothesis linking PKC-eta expression with the regulation and predisposition to the development of the iNOS phenotype in severe RA patients. PKC-eta may therefore be a key regulator in the production of elevated plasma nitric oxide (NO) and corresponding circulating reactive nitrogen intermediates in severe RA and may be a possible target to regulate iNOS induction and NO production by monocytic cells in RA patients and possibly other inflammatory diseases.
AuthorsCatherine Elizabeth Heale, Goverdina Elisabeth Fåhraeus-Van Ree, Proton Rahman, Vernon John Richardson
JournalThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society (J Histochem Cytochem) Vol. 55 Issue 5 Pg. 495-503 (May 2007) ISSN: 0022-1554 [Print] United States
PMID17242466 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Nitric Oxide
  • Nitric Oxide Synthase Type II
  • protein kinase C eta
  • Protein Kinase C
Topics
  • Adult
  • Arthritis, Rheumatoid (enzymology, physiopathology)
  • Biomarkers (blood)
  • Female
  • Fluorescent Antibody Technique
  • Humans
  • Male
  • Microscopy, Confocal
  • Middle Aged
  • Monocytes (enzymology)
  • Nitric Oxide (blood)
  • Nitric Oxide Synthase Type II (biosynthesis, blood)
  • Optics and Photonics
  • Phenotype
  • Protein Kinase C (biosynthesis, blood)
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: